Prathyusha Duraibabu - 18 Feb 2026 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)

Reporting relationship: Director
Issuer ticker: ORGO
Reported as of: 18 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Feb 2026, 17:26:16 UTC
Prior SEC filing: 26 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ William R. Kolb, Attorney-in-Fact

Key filing fact

Prathyusha Duraibabu filed Form 4 for Organogenesis Holdings Inc. (ORGO) on 20 Feb 2026.

Key facts

This page summarizes Prathyusha Duraibabu's Form 4 filing for Organogenesis Holdings Inc. (ORGO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 Feb 2026, 17:26.

Change

Previous filing in this sequence was filed on 26 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001779092 Primary reporting owner

Duraibabu Prathyusha

Relationship: Director
Address: C/O ORGANOGENESIS HOLDINGS INC., 85 DAN ROAD, CANTON
Signature: /s/ William R. Kolb, Attorney-in-Fact
Signature date: 20 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ORGO transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +48,828
Change %: +25%
Price: $0.000000
Shares after: 247,047
Date: 18 Feb 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2027.